The DABOM

Seoul, South Korea Founded: 2021 • Age: 5 yrs
Produces artificial exosomes for medical applications via advanced platforms.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors 10 Brand Intelligence

About The DABOM

The DABOM is a company based in Seoul (South Korea) founded in 2021. It operates as a B2B and SaaS. The DABOM offers products and services including Exocure TM and Exostation TM. The DABOM operates in a competitive market with competitors including Biological Dynamics, Sirnaomics, Acorda, Liquidia and Genedit, among others.

  • Headquarter Seoul, South Korea
  • Sectors
    Healthcare
    Technology
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Legal Name 주식회사 더다봄
  • Jurisdiction Na, Maharashtra, India
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Technology → Artificial Intelligence & Machine Learning Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of The DABOM

The DABOM offers a comprehensive portfolio of products and services, including Exocure TM and Exostation TM.

Product name locked
Category locked
Primary

Artificial exosomes for therapeutic medical applications.

Product name locked
Category locked
Locked

System for mass-producing artificial exosomes using AI.

Funding Insights of The DABOM

Premium access

Detailed funding history for The DABOM

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by The DABOM

Investments
Premium access

Investment portfolio details for The DABOM

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - The DABOM

Premium access

Detailed financials for The DABOM

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

The Dabom Comparisons

The DABOM Primary company
Description
Produces artificial exosomes for medical applications via ad...
Location
Seoul, South Korea
Founded Year
2021
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for The DABOM

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of The DABOM

The DABOM operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biological Dynamics, Sirnaomics, Acorda, Liquidia and Genedit, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Proprietary lab-on-chip platform for nanoparticle isolation is offered.
Locked Locked Locked
RNA-based therapeutics for cancer and fibrosis are developed.
Locked Locked Locked
Engaged in the development and commercialization of therapies that improve neurological function.
Locked Locked Locked
Engineered particles & films for life and material sciences applications
Locked Locked Locked
Genetic medicines are delivered using polymer nanoparticle platforms.
Locked Locked Locked
Drug delivery systems to cell interiors are developed via nanosyringes.
Premium access

Detailed competitors of The DABOM

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on The Dabom

Premium access

Complete news archive for The DABOM

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about The DABOM

The DABOM was founded in 2021.

The DABOM is headquartered in Seoul, South Korea.

The DABOM is a South Korean company that utilizes microfluidics and artificial intelligence to mass-produce artificial exosomes for nanomedicine. They offer platforms like Exocure TM for therapeutics and Exostation TM for production, focusing on RD and partnerships. Based in Seoul, they participate in conferences and collaborate with institutions for exosome-based innovations, advancing healthcare technology.

The DABOM's top competitors include Sirnaomics, Arcturus Therapeutics and Acorda.

The DABOM offers Exocure TM and Exostation TM.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available